Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib
ClinicalTrials.gov study NCT06280105. IPD Sharing: NO. Countries: 1. Publications: 0.
Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases
ClinicalTrials.gov study NCT05894837. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04450836. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy
ClinicalTrials.gov study NCT05811481. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
ClinicalTrials.gov study NCT06911684. IPD Sharing: NO. Countries: 1. Publications: 0.
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
ClinicalTrials.gov study NCT05057052. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT05818267. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy
ClinicalTrials.gov study NCT01959269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.
ClinicalTrials.gov study NCT03944304. IPD Sharing: NO. Countries: 1. Publications: 0.
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06992648. IPD Sharing: NO. Countries: 1. Publications: 0.
Baseline tumor features and peripheral blood immune dynamics that underlie efficacy in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumab [Blood]
GEO Series GSE289582. Homo sapiens. 115 samples. Type: Expression profiling by high throughput sequencing.
Combination of dual JAK/HDAC inhibitor with regorafenib reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
GEO Series GSE252554. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
Proteoglycan 4 and regorafenib synergistically reduce HCC progression in an orthotopic model
GEO Series GSE299840. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma
GEO Series GSE248155. Mus musculus. 31 samples. Type: Expression profiling by high throughput sequencing.
Expression data from cholangiocarcinoma cell lines and regorafenib treatment.
GEO Series GSE149131. Homo sapiens. 6 samples. Type: Expression profiling by array.
Role of regorafenib in macrophage and in antitumor immunity in hepatocellular carcinoma
GEO Series GSE148950. Mus musculus. 38 samples. Type: Expression profiling by high throughput sequencing.
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
GEO Series GSE301139. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer
ClinicalTrials.gov study NCT06283303. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer
ClinicalTrials.gov study NCT06283134. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Regorafenib + Panitumumab for Colorectal Cancers
ClinicalTrials.gov study NCT02199223. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.